The new RVN Council members are: Emily Bacon RVN, Macauly Gatenby RVN, Dan Lidgbird RVN and Krishna Mistry RVN, with Alice Langstone taking the student seat.
The incoming BVNA officer team for the 2025/6 term is (pictured left to right): Sarah Holliday RVN – President, Lyndsay Hughes RVN – Senior Vice President, Steph Worsley RVN – Junior Vice President, Nikki McLeod RVN – Honorary Secretary, Hamish Morrin RVN – Honorary Treasurer.
Nutraotic contains grapeseed oil, cinnamon, oregano, clove and lemongrass, a formulation which Nutravet says is designed to provide anti-bacterial, anti-fungal and anti-inflammatory support.
The company claims it helps cleanse and moisturise the ear canal, reduce ear odours and break down earwax, while maintaining a balanced ear flora to help prevent infections.
Chris Jones, Managing Director of Nutravet said: “Our goal with the Nutraotic range is to provide pet owners and veterinary professionals with products that offer safe, natural solutions to common pet ear issues.
“We recognise that ear health in dogs and cats is a frequent concern, and with the launch of the Nutraotic Ear Essential Oil, we’re expanding our ability to support pets in a way that’s effective and gentle.
"This product has been developed to make ear care simple and stress-free while using only the highest quality ingredients.”
www.nutravet.com
The course offers practical tips and is also designed to help veterinary professionals understand their obligations under the Code of Professional Conduct when discussing costs with clients.
RCVS CEO Lizzie Lockett said: “Discussions around the costs of veterinary treatment are not always easy and can sometimes give rise to misunderstandings or lack of clarity between clients and veterinary teams.
"We recognise the challenges these conversations present and the pressures veterinary professionals face.
“Meanwhile, the ongoing Competition and Markets Authority (CMA) investigation has highlighted that animal owners are not always satisfied with the level of information they receive in order to make an informed choice about treatment options.
This course supports the development of veterinary surgeons’ and veterinary nurses’ communication skills so that they can discuss treatment costs more transparently with their clients, helping to reduce potential misunderstandings and build trust.”
The course takes 45 minutes to complete and features an interactive scenario as well as expert video advice from experienced veterinary surgeons.
https://academy.rcvs.org.uk
The procedure has already been performed in the US and Germany, where it is reported to have had a success rate of 70-80% in around 250 cases, many of which were show jumpers, eventers and dressage horses.
The team at Liphook, led by European Specialist Rachel Tucker (pictured), has now performed the procedure on six horses.
Rachel said: “Enlargement of the articular process joints of the lower neck is a relatively common finding in horses, but occasionally this can cause compression and irritation of the spinal nerves.
"The foraminotomy procedure means horses experiencing nerve pain can be made comfortable and have a good chance of returning to ridden work and a competition career.
“The surgery is minimally invasive but it is a very delicate procedure to perform because you are working very close to the spinal cord.
"Due to the location, the surgery is performed down a single portal under direct visualisation using a camera, guided by ultrasound and X-ray.
"What has been remarkable so far has been the rapid recovery of the horses, who have been home and out in a small paddock within a few days of surgery with some showing rapid signs of improved comfort and movement.
“We are very pleased with how the procedures at Liphook went.
"Our patients are continuing to recover well and we are looking forward to following their progress in the future.
The six-floor building, which the College bought for £22.3m in 2022, was originally a warehouse.
Over the years it has been home to a range of businesses from leather manufacturers and papers makers to lithographic plate makers and shoe upping manufacturers, before becoming an office space.
The building remained tenanted until 2024, when £5.8m worth of renovation work to convert the building into a space suitable for a royal college began.
In addition to the working areas for RCVS and RCVS Knowledge staff, the building also has:
RCVS CEO, Lizzie Lockett, said: “After a few years in a rented co-working office space, we’re delighted to have moved into our new home, designed not only to meet the needs of College staff, but to support the broader ambitions of the RCVS as a whole.
“Our new strategic plan has collaboration at its heart – the idea of being stronger through working together – and our new building will help us to achieve that.
“Whether attending events, exploring RCVS Knowledge’s archives, using the members' area and meeting rooms, or benefitting from the outputs that the new space enables, the building has been developed with members and associates as a central focus.”
RCVS President, Linda Belton, added: "It’s great to see what’s been achieved through this project and my thanks go to the team who have managed the refurbishment and move.
“The new premises are equipped to ensure that the voice of the veterinary professions remains integral in assuring animal health, welfare, and public health in the UK, allowing for those all-important stakeholder conversations essential to setting, upholding and advancing veterinary standards.
“We look forward to welcoming members, associates, students and stakeholders alike in the coming months and years.”
This allows patients to try the drug at lower cost, before progressing to the 30ml bottle for ongoing treatment.
Samantha Taylor, RCVS Recognised Specialist in Feline Medicine said: “It’s great we now have the option to prescribe the smaller 12ML bottle for starting cats on Senvelgo, as it means we don’t have to worry about wasting a 30ml bottle if it becomes evident that the cat requires insulin in the first couple of weeks.”
https://senvelgo.co.uk
Clare (pictured) who is currently the General Dental Council’s Interim Executive Director for Legal and Governance, will be joining the RCVS as its most senior legal officer at the end of March 2025.
A qualified solicitor, Clare started her practice as a Solicitor Advocate in criminal law, before undertaking roles in regulatory bodies in the healthcare and financial sector.
She joined the General Dental Council in March 2023 and has been in her current role there since March last year.
When she joins the College, Clare will have a dual role.
As Registrar she will be responsible for keeping, maintaining and publishing Registers of veterinary surgeons and veterinary nurses, including oversight of the various mechanisms via which veterinary professionals can join the Register, what they need to do to stay on the Registers, how they may leave or be removed and registration appeals.
As Director of Legal Services, she'll provide leadership and guidance on legal matters within the organisation, including guiding RCVS Council through the development of oral and written legal advice, as well as sitting on committees and working groups in order to ensure the College’s activity is within its legal remit and represents best practice.
RCVS Chief Executive Officer Lizzie Lockett said: “I am sure the RCVS, the professions and the public will benefit from her very relevant experience from senior roles within the General Dental Council, Nursing and Midwifery Council, and Financial Conduct Authority, as well as her private sector legal experience.
“She joins the College at a time of change, with our continued push for new veterinary legislation, the ongoing Competition and Markets Authority investigation of the sector, and a new strategic plan for the College due to be approved this spring.
“The Registrar is the senior legal figure within the organisation, and I am looking forward to Clare contributing her legal expertise on these significant areas of work.
"She joins our very capable legal team, who I am sure will benefit from her leadership, as she will benefit from their sector expertise.”
Clare said: “I am delighted to join the Royal College of Veterinary Surgeons to contribute to the valuable work of safeguarding the interests of the public and animals by supporting veterinary professionals to provide the highest standards of care.”
VetNurse.co.uk extends a warm welcome to Clare and wishes her all the very best in her new position.
One small but nevertheless important point is that perhaps a better aim would be to support veterinary professionals in providing just a 'high' standard of care, rather than the 'highest' standards.
It's this constant striving for the 'highest' standards from both a regulatory and clinical perspective that is driving up the cost of veterinary care and making it unaffordable.
Great Workplaces by BVA is an accreditation scheme designed to recognise and reward positive workplace culture in both clinical and non-clinical veterinary workplaces.
The first webinar: 'How to have more good days at work' will be hosted by BVA Junior Vice President, Rob Williams (pictured), and VDS Training’s Carolyne Crowe.
The speakers will discuss strategies to support physical and psychological wellbeing at work and explore how to create a safe and inclusive team environment that supports everyone's needs.
Rob said: “This webinar series is designed to help your team identify practical steps to improve your veterinary workplace and create a working environment that allows the whole team to thrive.
"We’ll be diving into the first session with lots of practical tips and strategies and I hope to see many of you there.”
https://www.bva.co.uk/great-workplaces
https://mybva.bva.co.uk/ems-event-calendar/building-great-workplaces-how-to-have-more-good-days-at-work.html
The guide is aimed at established practices, new start-ups and those who may be thinking about setting up a practice.
It includes practical information, videos and first hand advice from independent practice leaders who are members of Vetsure and who've successfully navigated the challenges of practice ownership and management.
In the book, Diane Storer of Cockburn Vets offers tips for recruiting and building a collaborative team, whilst Julie Hutton of Hilltop Vets shares her thoughts on leadership and addressing practice challenges.
Other contributors to the guide include Vicki Farbon of Scott Veterinary Clinic, Kate Hornby of Wild Side Vets, Emily Nightingale of Nightingale Vets and Simon Hayes of Creature Comforts, who draw from their diverse experiences of founding and operating independent practices.
Ashley Gray, Managing Director of Vetsure said: “The insights from successful independent practice owners and Vetsure network members included in the guide offer lessons from real experiences beyond generic business courses."
He added: “The Vetsure network aims to support and champion independent veterinary practices by sharing knowledge and expertise, facilitating learning from fresh perspectives and ideas, and fostering genuine collaboration,”
https://www.vetsurevet.com/guide-to-success
Across Europe, the company has over 30 technical experts who get over 2,500 technical calls each year about Cushing’s.
The company also publishes the Dechra Academy, which provides a range of free online courses for vet nurses.
There's also Dechra’s endocrinology app which was developed using data from the Royal Veterinary College’s VetCompass database to help vets diagnose and manage the endocrine disorders Addison’s disease (hypoadrenocorticism) and Cushing’s syndrome.
For owners, Dechra publishes the 'Suspecting Cushing’s' website and has created the Cushing’s monitoring app to help simplify the management process, improve compliance with medication and increase engagement in the dog’s care.
Sarah Musgrave, companion animal brand manager at Dechra, said: “Dechra has extensive experience in endocrinology.
"Cushing’s can be a challenge to identify, diagnose and manage and our ‘They’ve got Cushing’s. You’ve got us’ initiative demonstrates the comprehensive support that we have available for both vets and dog owners to help ensure that dogs with Cushing’s live long and healthy lives.”
https://www.dechra.co.uk/cushings-connect
The range will include Vetoryl 20mg, 30mg and 60mg hydrolysed chicken flavoured tablets, which can be broken into halves or quarters.
The new Vetoryl tablets will come in packs of 30 tablets, although no word from Dechra as to when they'll arrive.
Thomas Johnson, Vetoryl brand manager at Dechra, said: “We are delighted that Vetoryl Flavoured Tablets for Dogs will soon be available, which will provide vets and pets owners with easy to administer, flavoured tablets to provide additional dosing flexibility.
"This, together with our commitment to providing extensive technical support and resources, will ensure that Vetoryl continues to be the UK’s leading licensed medical treatment for Cushing’s syndrome.”
The new consumer products, which include surface disinfectants, a stain and odour remover, a urine eliminator, a laundry sanitiser and a carpet cleaner, are being rolled out first on Amazon.
Broadly speaking, they contain the same active ingredients as the professional range used in practice, but formulated for consumer use.
The company says that whilst e-commerce is its initial priority, traditional retail remains an important part its long-term strategy, and it is interested to hear from any veterinary practices that would like to retail the range.
https://anigene.co.uk
https://byotrol.com
https://www.amazon.co.uk/stores/Byotrol/page/85CD32DA-4253-4A04-AB24-D6F9ECC9BCD3
The study analysed 321 canine cases reported to the VPS for electronic cigarette or e-liquid exposure, to assess the risk of nicotine toxicosis in dogs.
53% of dogs remained asymptomatic after oral exposure to e-liquid and 41% developed only mild signs.
Among the 47% that developed clinical signs, emesis, hypersalivation, and tachycardia were the most common.
Other potential signs of nicotine toxicity, such as tremor, ataxia, or tachypnoea, occurred in less than 7% of cases.
Clinical signs generally resolved within a few hours, with a median recovery time of 3 hours, varying from 10 minutes to 6 days.
28% of the dogs received no treatment or observation only, and 45% received gut decontamination, most commonly activated charcoal only or oral lavage only.
Two dogs required the removal of a foreign body (an electronic cigarette and an e-liquid refill bottle).
A moderate, severe or fatal outcome was reported in 6% of cases.
Two dogs died; one after chewing a bottle of e-liquid, and experiencing progressive tachypnoea, persistent tachycardia and hypotension, and one was euthanised due to financial constraints.
The severity of poisoning wasn’t related to the reported dose, and it’s not clear why large doses didn’t cause severe nicotine toxicosis.
The authors conclude that the majority of dogs exposed to e-liquids can be managed conservatively and treatment is symptomatic and supportive.
Nicola Bates, lead author of the study, said: “Although severe effects following exposure to e-cigarettes or e-liquid is uncommon in dogs, each case should be assessed on a case-by-case basis to determine if any decontamination or treatment is required”.
https://onlinelibrary.wiley.com/doi/10.1111/jsap.70014
Reference
Conducted as a multicentric international study involving board-certified veterinary dermatologists, the trial included 35 dogs with CIF in at least two paws.
Each dog acted as its own control, and was treated with systemic antibiotics, with one paw being treated with FLE and the other paw without.
Paws were allocated based on a coin toss, and the study was single blinded: the principal investigator was responsible for the assessment of lesions, and the co-investigator was responsible for administration of FLE treatment.
The dogs were assessed over an 8-week period with check-ups every 14 days.
At every check-up the paws treated with FLE showed a greater improvement than paws without FLE treatment.
The lesions were assessed and scored with the global lesion score, the pruritic visual analogue scale, a cytological scoring, and photographic documentation.
The results of the study demonstrated that FLE combined with systemic antibiotics significantly reduced the time to clinical resolution compared to antibiotics alone.
By week four, 50% of paws in the FLE group had reached clinical resolution compared to 17% in the control group.
By week eight, 88% of paws in the FLE group had healed compared to 54% in the control group.
Dr Anja Lange, DVM, Department of Dermatology, AniCura Kleintierspezialisten Augsburg GmbH, Augsburg, Germany, said: “Canine interdigital furunculosis is a challenging condition to treat that can be prolonged and frustrating.
"Having FLE as an additional management tool is very exciting, not least because it speeds up time to healing, but it also requires us to use less antibiotics.
"The use of FLE was well accepted by all of the dog owners from the study and the dogs themselves tolerated it well, showing it can be a very useful adjunct to cases in clinical practice.”
The ERP was established in 2016 when it emerged that an increasing number of research projects were being conducted in private veterinary practices. In these settings, researchers may not always be familiar with the regulations and the ethical best practice needed for clinical veterinary research.
The ERP reviews both prospective and retrospective research projects on cats, dogs, horses and farm animals. As well as reviewing animal-based research, the panel also reviews sociological studies involving veterinary staff.
There are currently seven available spaces on the panel, and the RCVS is looking to fill the spaces with:
The Panel is Chaired by Professor David Morton, who said: “I’ve been honoured to Chair the Ethics Review Panel for the last five years. Through my role as Chair, I have had the opportunity to work alongside some exceptional veterinary professionals and I encourage anyone with a keen interest in clinical veterinary research to apply for a position on the Panel.”
To apply, visit www.rcvs.org.uk/ethics-panel and send a completed application form and CV to ethics@rcvs.org.uk.
The deadline for applications is 5pm on Friday 16 July 2021.
Rowe Referrals, part of IVC Evidensia Referrals, was one of the very first practices to have an onsite MRI when it installed a 1.5T model five years ago. Now, thanks to investment from IVC Evidensia - of which it is a part - Rowe has been able to replace the ageing model with a new 3.0T machine, which will enable clinicians to diagnose and implement treatment plans quicker.
Referrals Manager at Rowe Referrals, Meg Hayman, said: "The difference between the two machines in amazing. The 1.5T produced very detailed scans but the 3.0T is incredible! It gives our clinicians the ability to perform more complex investigations with far greater clarity.
The practice says benefits will be seen across all disciplines, including neurology, internal medicine, ophthalmology, dentistry, orthopaedics and soft tissue.
Ian Jennings BSc BVSc CertVDI MRCVS RCVS Advanced Practitioner in Diagnostic Imaging said: "The new 3.0T MRI scanner allows us a much more detailed view of our patients, and has been especially useful for detection of smaller lesions in our neurological and orthopaedic cases. Specialised sequences can also be performed in less time, allowing us a greater ability to help more patients."
This year, there were over 41,000 nominations for the five awards which were set up 26 years ago to recognise the nation’s most outstanding veterinary professionals.
The other four winners were:
Vet of the Year: Claire Phillips, Wright & Moreton, Cheshire
Practice of the Year: Coastal Veterinary Group, King’s Lynn
Practice Support Staff of the Year: Hannah Reid, Westport Veterinary Clinic, South Queensferry
Practice Manager of the Year: Fiona Leathers, Westport Veterinary Clinic, South Queensferry
Joanna Maclennan, Director of Trading at Petplan said: “A highlight in our calendar, last night was an evening of celebration of the incredible work that goes on in veterinary practices on a daily basis."
The new law allows the Government to:
require that the owner travels with the pets, or within 5 days of the pets arriving.
Danny said: “As a vet, I've treated many dogs with cruelly cropped ears or docked tails, leaving them physically scarred and emotionally traumatised.
"Knowing this Bill will help us put a stop to this abuse and have a bigger impact on animal welfare than I could possibly have achieved in a lifetime treating individual animals, demonstrates how important this legislation will prove to be.
"Thanks to the support of organisations like the BVA and other animal welfare nonprofits, we got the Animal Welfare Bill through the Commons, through the Lords, and today passed into law."
The company now expects the vaccine will not be available until June 2025.
The company apologised for the disruption and inconvenience and says it will provide more information as soon as it becomes available.
For further information contact your Zoetis Account Manager or call Head Office on 0345 300 8034.
The update includes a new scoring system of low, moderate or high cancer risk which replaces the original numerical HDI scores and simplifies interpretation for clinicians, making the screening process easier to communicate with pet owners.
HT Vista says the device can now categorise cancer risk levels, based on malignant probability, with a sensitivity of 90% and a negative predictive value (NPV) of 98%.
The company says this translates to a “low cancer risk” result having a malignant probability of 10% or less, allowing veterinary teams to rule out cancer of lumps and bumps without the need for invasive procedures.
The tool can also now provide alerts for some of the low-risk cases, identifying them as lipomas, sebaceus adenomas or benign epithelial masses.
Liron Levy-Hirsch DVM MRCVS, Managing Director at HT Vista, said: "I am incredibly excited to enhance our already powerful HT Vista screening tool with a new diagnostic capability, providing veterinary teams with an even more comprehensive decision-support system.
"Our screening technology has already been a game-changer in early detection, and now, with the ability to flag specific tumour types, we are taking another significant step forward.
"This advancement empowers veterinary professionals to make even more informed decisions, supports shared decision-making with pet owners, and ultimately improves patient outcomes.
"By reducing the time from suspicion to diagnosis and treatment, we can detect cancer earlier, avoid the ‘wait and see’ approach, and help save more lives."
On the other end of the scale, a “high cancer risk” result has a malignant probability of 50% or more and indicates a stronger likelihood of malignancy.
HT Vista says these cases require additional diagnostic tests for mass identification.
The company highlights a big distinction between this and other screening modalities is that it can be nurse-led.
HT Vista will be on display and there will be live demonstrations at BSAVA Congress from the 20th to the 22nd of March 2025.
https://bit.ly/ht-vista-screening-tool
The report comes on the back of a survey by the association which found that 93% of vets say sustainability is important to them.
The BVA says the report aims to break down the challenge that both teams and individuals face in working towards net zero emissions.
It explains the impact of climate change, what the veterinary profession’s role is in tackling it and why the BVA thinks it is so important that the profession plays its part.
The report also includes resources and showcases the ways real veterinary workplaces are taking action to reduce their impact on the environment.
British Veterinary Association Senior Vice President Anna Judson said: “Many veterinary professionals have long been concerned about the impact the sector is having on the environment, and many are already taking action to mitigate this.
"However, there is still more work to do.
"Our vision is that by 2050 the profession will have adapted to support the UK’s net zero targets; is trusted on mitigating its own carbon footprint; and is a leading advocate for environmental sustainability.
"This new report is providing vet teams with the tools and the inspiration to do their bit, because small changes add-up to make a big difference.”
There'll be a session on the subject at the London Vet Show this year, chaired by Anna Judson, with panelists Ed Bailey, Clinical Director and Sustainability Lead at George Farm Vets, Laura Binnie, Sustainability Lead at Paragon Veterinary Group and James Bevan, Planetary Health Senior Teaching Fellow Public Health Registrar, University of Southampton.
"Practice what you preach: Reaching net zero is a team effort" will be held at 10.45am - 11.45am on 14 November in the BVA Congress Theatre.
www.bva.co.uk/net-zero-report
The new oncology department has a dedicated chemotherapy room, access to a variety of chemotherapy drugs and a fully equipped operating theatre – offering soft tissue and orthopaedic surgery services for surgical oncology cases.
The department also has access to high frequency ocular ultrasound, magnetic resonance (MRI), and computed tomography (CT) scan equipment.
The service will be led by residency-trained clinician in Small Animal Oncology, Nina Vigevani DVM MRCVS.
She graduated in 2019 from the University of Milan, completed a rotating internship and worked in general practice in Milan, before moving to the UK to start on an oncology internship at a referral practice in the South of England.
Prior to moving to Chestergates, she completed her Residency in Small Animal Oncology at the University of Liverpool.
https://chestergates.org.uk/referral-services.
The patient was a four-year-old Labrador called Vinny who, in 2019, became the first dog in the UK to receive a BioMedtrix canine ankle replacement system, implanted by Wear's Head of Orthopaedic Surgery, RCVS Specialist Neil Burton, assisted by Maciej Krukowski.
That first surgery, on Vinny’s right ankle, was successful. However, two years later he needed similar treatment to his left leg.
Neil said: “Vinny first presented to us at Wear Referrals in 2019 with hind limb lameness.
“He was diagnosed with osteoarthritis in his hock joints bilaterally due to a developmental condition called osteochondrosis of the talus causing him ongoing pain and lameness. We operated on the right ankle, with Vinny becoming the first dog in the UK to have this ankle replacement system placed.
“Vinny was significantly more comfortable on this limb postoperatively but his lameness progressively worsened in the left hind limb. The decision was made to perform the same surgery on the left ankle, making Vinny the first dog in the world to have this surgery performed bilaterally.
“Vinny has made another fine recovery from surgery and is now off medication, meaning he can exercise unrestricted and pain-free without a lifetime reliance on painkilling drugs.
“For our team at Wear to be able to offer him this pioneering surgery has been a great opportunity. He’s now a unique case, being both the first UK recipient of this BioMedtrix joint replacement as well as the world's first bilateral ankle replacement with the same system.”
For more information, visit www.wear-referrals.co.uk.
The panel will present the latest information on the prevalence of this zoonotic disease, review prevention strategies, and highlight the significance of cystic echinococcosis in humans.
The panelists are:
Dr Carolyn Kyte MRCVS (pictured), Elanco's UK Technical Consultant said: “We are concerned about potential changes in the distribution of Echinococcus granulosus in the UK and a subsequent change in zoonotic risk.
"We are hoping this cross-disciplinary discussion will provide Congress and Expo attendees with the latest insights the profession needs to allow individual, risk-based parasite control in dogs.
"The responsible use of parasiticides needs a true One-Health collaborative approach.”
ESCCAP says that the risk of novel parasites and zoonoses spreading to new regions has risen alongside an increase in pet travel and changing climate conditions.
ESCCAP’s Guideline 09 offers detailed advice on how to protect dogs and cats that travel or are imported across European borders, minimise the risk of zoonotic transmission and prevent the establishment of new parasites in previously unaffected areas.
Topics covered in the guideline include:
The guideline emphasises the importance of early detection of parasitic infections by thorough clinical examinations, comprehensive travel history assessments and targeted diagnostic testing.
It also provides guidance on educating pet owners about zoonotic risks and implementing appropriate treatments and follow-up screenings.
www.esccap.org/guidelines/gl9/